Category Archives: biotechnology

How a Digital Strategy can Help Healthcare Solve the Triple Aim

By Peggy Salvatore MBA I am writing this in possibly the biggest week for health tech junkies all year. Last week, the Consumer Electronics Show (now simply known as CES) rolled out acres of new tech toys, many of them … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | 2 Comments

Join us at ePharma Summit 2016 in New York City Next Month

By Peggy Salvatore MBA For the next two months, Health System Ed will be blogging about the ePharma Summit 2016 that will be held in NYC from February 29 to March2. Check out the conference details here. With my background … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Holiday 2015 Edition of Health Wonk Review

                      Happy Holidays from Health Wonk Review, as we celebrate another year of news and commentary…okay, mostly commentary. Here’s our last blast for 2015. Many thanks to Julie Ferguson of … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management | Leave a comment

Challenge: Consumer Healthware and the Glut of Unstructured Patient Data

By Peggy Salvatore Remember the good old days, when times were simpler, and health technology was all about electronic patient records? Not today. The world of health technology is about telemedicine, wearables, data collection and privacy. The vast amount of … Continue reading

Posted in biotechnology, electronic patient records, health economics, health IT, health policy, health reform | Leave a comment

A Patient’s Bill of Rights: Possible Counterbalance to Value-Based Payment

Last week’s blog explored the relationship between collection of patient data and value-based payment for patient outcomes. The fact that payments will be driven by data is one of the lesser recognized drivers of data collection, but it is of … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform | Leave a comment

A Norman Rockwell Counting Our Blessings Edition of Health Wonk Review

              Such a beautiful, American scene! Freedom From Want by Norman Rockwell. Many special thanks to Brad Wright for this lovely Thanksgiving Day Count Our Blessings Edition of Health Wonk Review.  (Eeek, I have … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management | Tagged | Leave a comment

Health Wonk Review: The Selfie Edition

Get your Selfie stick ready to take a photo of your expression as you work your way through this edition of Health Wonk Review. You’ll capture a smile on your face, I’m sure. For pure delight, nothing matches this roundup … Continue reading

Posted in biotechnology, electronic patient records, health economics, health IT, health policy, health reform, healthcare change management | Leave a comment

A Regulatory Morass*

Or Why health technology is more exciting than electronic patient records By Peggy Salvatore MBA *Definition 1: An area of muddy or boggy ground. Definition 2: A complicated or confused situation. For many years, the promise of electronic patient records … Continue reading

Posted in biotechnology, electronic patient records, health economics, health IT, health policy, health reform | Leave a comment

Finally, Research Solves Scarecrow’s Problem

By Peggy Salvatore MBA “If I only had a brain.” – Scarecrow, Wizard of Oz Here’s the latest place where research, technology, medicine and biology meet in new and amazing ways. From The Guardian on August 18, 2015: An almost … Continue reading

Posted in biotechnology, health policy, healthcare change management | 2 Comments